Literature DB >> 30929820

Disorganization of Retinal Inner Layers and Ellipsoid Zone Disruption Predict Visual Outcomes in Central Retinal Vein Occlusion.

Errol W Chan1, Mohab Eldeeb2, Vincent Sun3, Doneal Thomas4, Amer Omar5, Michael A Kapusta6, Ivan J Galic1, John C Chen7.   

Abstract

PURPOSE: To assess the associations and predictive value of spectral-domain (SD) OCT inner and outer retinal structural parameters and visual acuity (VA) outcomes in macular edema (ME) secondary to central retinal vein occlusion (CRVO).
DESIGN: Retrospective, longitudinal cohort study. PARTICIPANTS: Eighty-four patients with ME secondary to CRVO receiving pro re nata anti-vascular endothelial growth factor (VEGF) therapy at 3 tertiary-level retina referral centers.
METHODS: In all participants, VA, demographic and clinical parameters, and SD OCT images from baseline, 3 months, and 12 months were reviewed. Spectral-domain OCT-based morphologic features in the 1500-μm foveal zone were analyzed by masked graders for disorganization of the retinal inner layers (DRIL), ellipsoid zone (EZ) and external limiting membrane disruption, cone outer segment tip (COST) visibility, cysts, subretinal and intraretinal fluid, and epiretinal membranes. MAIN OUTCOME MEASURES: Spectral-domain OCT-based retinal structural parameters and VA outcomes.
RESULTS: In multivariate analyses adjusting for baseline VA, worsening VA over 1 year was associated with 1-year increases in DRIL (point estimate, 0.06 per 100 μm; P < 0.001) and EZ disruption (0.07 per 100 μm; P = 0.023), but decreased COST visibility (-0.09 per 100 μm; P = 0.018). A 3-month increase in DRIL (0.05 per 100 μm; P = 0.003) and EZ disruption (0.10 per 100 μm; P < 0.001) were the only factors predicting VA worsening over 1 year, after controlling for baseline VA. A multivariate model including 3-month evolution in DRIL, EZ disruption, and VA accounted for 86.3% of variability in 1-year VA change. Absolute differences between predicted and actual 1-year VA were within 2 lines in 80.9%. When DRIL increased by 250 μm or more over 3 months, no eyes showed VA improvement of 1 line or more in 1 year. When EZ disruption decreased by 250 μm or more over 3 months, no eyes worsened by 1 line or more over 1 year.
CONCLUSIONS: Early recovery over 3 months in both DRIL and EZ parameters are key drivers of 1-year VA outcomes. Predictive models incorporating 3-month changes in DRIL and EZ disruption support their usefulness as potential robust determinants of future VA.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Year:  2018        PMID: 30929820     DOI: 10.1016/j.oret.2018.07.008

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN: 2468-6530


  15 in total

1.  Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT.

Authors:  Sophie Z Gu; Onnisa Nanegrungsunk; Susan B Bressler; Weiming Du; Fouad Amer; Hadi Moini; Neil M Bressler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-24       Impact factor: 3.117

2.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

3.  Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.

Authors:  Glenn Yiu; R Joel Welch; Yinwen Wang; Zhe Wang; Pin-Wen Wang; Zdenka Haskova
Journal:  Ophthalmol Retina       Date:  2019-08-28

4.  LONGITUDINAL ELLIPSOID ZONE AND OUTER RETINAL INTEGRITY DYNAMICS AFTER EPIRETINAL MEMBRANE SURGERY.

Authors:  Tisileli S Tuifua; Joseph R Abraham; Sunil K Srivastava; Peter K Kaiser; Jamie Reese; Justis P Ehlers
Journal:  Retina       Date:  2022-02-01       Impact factor: 4.256

5.  Spectral Domain OCT Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2: SCORE 2 Report 15.

Authors:  Tyler Etheridge; Barbara Blodi; Neal Oden; Paul Van Veldhuisen; Ingrid U Scott; Michael S Ip; Mihai Mititelu; Amitha Domalpally
Journal:  Ophthalmol Retina       Date:  2020-12-26

6.  A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular edema: SCORE2 pilot study.

Authors:  Tyler Etheridge; Ellen T A Dobson; Marcel Wiedenmann; Chandana Papudesu; Ingrid U Scott; Michael S Ip; Kevin W Eliceiri; Barbara A Blodi; Amitha Domalpally
Journal:  PLoS One       Date:  2020-04-30       Impact factor: 3.240

7.  Novel Optical Coherence Tomography Parameters as Prognostic Factors for Stage 3 Epiretinal Membranes.

Authors:  Young Gun Park; Seo Yeon Hong; Young-Jung Roh
Journal:  J Ophthalmol       Date:  2020-12-22       Impact factor: 1.909

8.  Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion.

Authors:  Maria I Avrutsky; Crystal Colón Ortiz; Kendra V Johnson; Anna M Potenski; Claire W Chen; Jacqueline M Lawson; Alexandra J White; Stephanie K Yuen; Fatima N Morales; Elisa Canepa; Scott Snipas; Guy S Salvesen; Ying Y Jean; Carol M Troy
Journal:  Nat Commun       Date:  2020-06-23       Impact factor: 17.694

9.  Comparison of SDOCT Scan Types for Grading Disorganization of Retinal Inner Layers and Other Morphologic Features of Diabetic Macular Edema.

Authors:  Konstantina Sampani; Marwan Abdulaal; Timothy Peiris; Michael M Lin; Cloyd Pitoc; Migil Ledesma; Jan Lammer; Paolo S Silva; Lloyd Paul Aiello; Jennifer K Sun
Journal:  Transl Vis Sci Technol       Date:  2020-07-30       Impact factor: 3.283

10.  Surgery outcomes of lamellar macular eyes with or without lamellar hole-associated epiretinal proliferation: a meta-analysis.

Authors:  Hanyue Xu; Ling Qin; Yifan Zhang; Yinan Xiao; Ming Zhang
Journal:  BMC Ophthalmol       Date:  2020-08-25       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.